SE341394B - - Google Patents
Info
- Publication number
- SE341394B SE341394B SE15414/65A SE1541465A SE341394B SE 341394 B SE341394 B SE 341394B SE 15414/65 A SE15414/65 A SE 15414/65A SE 1541465 A SE1541465 A SE 1541465A SE 341394 B SE341394 B SE 341394B
- Authority
- SE
- Sweden
- Prior art keywords
- hydroxy
- group
- formula
- etherified
- alkyl
- Prior art date
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 8
- 125000005843 halogen group Chemical group 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 5
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 150000002148 esters Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- -1 alkali metal alkoxide Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 238000006356 dehydrogenation reaction Methods 0.000 abstract 2
- 238000006704 dehydrohalogenation reaction Methods 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 230000026030 halogenation Effects 0.000 abstract 2
- 238000005658 halogenation reaction Methods 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000468 ketone group Chemical group 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- RZCJSVRGPHXBSM-UHFFFAOYSA-N 8-chloro-[1,3]dioxolo[4,5-g]quinazoline Chemical compound C1=C2C(Cl)=NC=NC2=CC2=C1OCO2 RZCJSVRGPHXBSM-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 101100241859 Mus musculus Oacyl gene Proteins 0.000 abstract 1
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229960000583 acetic acid Drugs 0.000 abstract 1
- 150000001350 alkyl halides Chemical class 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 125000000746 allylic group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 125000001033 ether group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000012362 glacial acetic acid Substances 0.000 abstract 1
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- BIZCJSDBWZTASZ-UHFFFAOYSA-N iodine pentoxide Inorganic materials O=I(=O)OI(=O)=O BIZCJSDBWZTASZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 235000006408 oxalic acid Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 abstract 1
- QYHFIVBSNOWOCQ-UHFFFAOYSA-N selenic acid Chemical compound O[Se](O)(=O)=O QYHFIVBSNOWOCQ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Conveying And Assembling Of Building Elements In Situ (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL226774 | 1958-04-12 | ||
| NL232312 | 1958-10-15 | ||
| NL236884 | 1959-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE341394B true SE341394B (en, 2012) | 1971-12-27 |
Family
ID=27351008
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE3390/59A SE342814B (en, 2012) | 1958-04-12 | 1959-04-09 | |
| SE15413/65A SE341398B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15415/65A SE341399B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15410/65A SE341397B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15412/65A SE341401B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15411/65A SE341400B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15414/65A SE341394B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15416/65A SE341848B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15417/65A SE342445B (en, 2012) | 1958-04-12 | 1965-11-29 |
Family Applications Before (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE3390/59A SE342814B (en, 2012) | 1958-04-12 | 1959-04-09 | |
| SE15413/65A SE341398B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15415/65A SE341399B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15410/65A SE341397B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15412/65A SE341401B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15411/65A SE341400B (en, 2012) | 1958-04-12 | 1965-11-29 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE15416/65A SE341848B (en, 2012) | 1958-04-12 | 1965-11-29 | |
| SE15417/65A SE342445B (en, 2012) | 1958-04-12 | 1965-11-29 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US3192201A (en, 2012) |
| AT (2) | AT287213B (en, 2012) |
| CH (14) | CH420130A (en, 2012) |
| CS (2) | CS149567B2 (en, 2012) |
| DE (1) | DE1253707B (en, 2012) |
| DK (7) | DK108571C (en, 2012) |
| ES (1) | ES248593A1 (en, 2012) |
| FI (2) | FI42083B (en, 2012) |
| FR (1) | FR953M (en, 2012) |
| GB (5) | GB929276A (en, 2012) |
| NO (1) | NO122835B (en, 2012) |
| OA (1) | OA02640A (en, 2012) |
| SE (9) | SE342814B (en, 2012) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH420130A (de) * | 1958-04-12 | 1966-09-15 | Philips Nv | Verfahren zur Herstellung neuer Steroide |
| NL295097A (en, 2012) * | 1962-07-10 | |||
| US3235573A (en) * | 1962-12-20 | 1966-02-15 | Syntex Corp | 19-lower alkylidene and 19-oxo-delta4-androsten-17beta-ol-3-one derivatives |
| NL123937C (en, 2012) * | 1963-11-06 | |||
| US3463852A (en) * | 1966-01-14 | 1969-08-26 | Schering Corp | Treating allergies with steroids of the pregnane series |
| CH476711A (de) * | 1966-06-10 | 1969-08-15 | Hoffmann La Roche | Verfahren zur Herstellung von neuen 9B,10a-Steroiden |
| GB1266361A (en, 2012) * | 1969-07-16 | 1972-03-08 | ||
| US5922699A (en) | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| CN113880904B (zh) * | 2020-07-01 | 2024-04-12 | 苏州朗科生物技术股份有限公司 | 合成地屈孕酮的新方法及化合物 |
| CN114057820B (zh) * | 2021-11-15 | 2023-06-27 | 湖南科瑞生物制药股份有限公司 | 一种地屈孕酮的精制方法 |
| CN114957370B (zh) * | 2021-12-06 | 2023-09-19 | 湖南醇康医药科技有限公司 | 一种地屈孕酮的制备和纯化方法 |
| CN114957369B (zh) * | 2021-12-07 | 2023-10-31 | 湖南醇康医药科技有限公司 | 一种地屈孕酮的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE882399C (de) * | 1937-11-28 | 1953-07-09 | Schering Ag | Verfahren zur Darstellung von 17-AEthinyl-?-androstenol-17-on-3 und dessen Derivaten |
| US2752337A (en) * | 1951-06-28 | 1956-06-26 | Upjohn Co | Steroid enamines |
| US2739974A (en) * | 1953-04-06 | 1956-03-27 | Searle & Co | Process of preparing delta4,6-3-ketosteroids |
| US2871245A (en) * | 1956-06-19 | 1959-01-27 | Ciba Pharm Prod Inc | New 1-dehydro-testosterones and esters thereof |
| US2867630A (en) * | 1958-06-09 | 1959-01-06 | Upjohn Co | 6-fluoro androstenes |
| CH420130A (de) * | 1958-04-12 | 1966-09-15 | Philips Nv | Verfahren zur Herstellung neuer Steroide |
| GB956691A (en) * | 1961-10-05 | 1964-04-29 | British Drug Houses Ltd | 3-unsubstituted-í¸-androstene compounds |
-
1959
- 1959-04-09 CH CH343766A patent/CH420130A/de unknown
- 1959-04-09 DE DEN16529A patent/DE1253707B/de active Pending
- 1959-04-09 SE SE3390/59A patent/SE342814B/xx unknown
- 1959-04-09 CH CH343666A patent/CH415613A/de unknown
- 1959-04-09 CH CH527966A patent/CH416612A/de unknown
- 1959-04-09 CH CH343966A patent/CH420131A/de unknown
- 1959-04-09 CH CH436166A patent/CH415614A/de unknown
- 1959-04-09 CH CH1881566A patent/CH441299A/de unknown
- 1959-04-09 CH CH527866A patent/CH415615A/de unknown
- 1959-04-09 CH CH436066A patent/CH428720A/de unknown
- 1959-04-09 CH CH344066A patent/CH432505A/de unknown
- 1959-04-09 NO NO131412A patent/NO122835B/no unknown
- 1959-04-09 CH CH343866A patent/CH434244A/de unknown
- 1959-04-09 CH CH344166A patent/CH432506A/de unknown
- 1959-04-09 CH CH343566A patent/CH455765A/de unknown
- 1959-04-09 CH CH343466A patent/CH430710A/de unknown
- 1959-04-09 CH CH7177059A patent/CH464183A/de unknown
- 1959-04-10 US US805436A patent/US3192201A/en not_active Expired - Lifetime
- 1959-04-10 CS CS2095A patent/CS149567B2/cs unknown
- 1959-04-10 CS CS1762A patent/CS161826B2/cs unknown
- 1959-04-10 ES ES0248593A patent/ES248593A1/es not_active Expired
- 1959-04-11 DK DK362761AA patent/DK108571C/da active
- 1959-04-11 DK DK363161AA patent/DK107871C/da active
- 1959-04-11 FI FI0624/59A patent/FI42083B/fi active
- 1959-04-11 AT AT03676/68A patent/AT287213B/de not_active IP Right Cessation
- 1959-04-11 AT AT06986/65A patent/AT281307B/de not_active IP Right Cessation
- 1959-04-11 DK DK126859AA patent/DK110201C/da active
- 1959-04-11 DK DK363061AA patent/DK103510C/da active
- 1959-04-12 GB GB639/63A patent/GB929276A/en not_active Expired
- 1959-04-12 GB GB639/63D patent/GB929279A/en not_active Expired
- 1959-04-12 GB GB12025/59A patent/GB929271A/en not_active Expired
- 1959-04-12 GB GB637/63A patent/GB929277A/en not_active Expired
- 1959-04-12 GB GB638/63A patent/GB929278A/en not_active Expired
-
1960
- 1960-08-30 FR FR837281A patent/FR953M/fr active Active
-
1961
- 1961-09-12 DK DK362961AA patent/DK124079B/da unknown
- 1961-09-12 DK DK362661AA patent/DK118503B/da unknown
-
1962
- 1962-11-08 DK DK481862AA patent/DK115038B/da unknown
- 1962-11-20 FI FI2082/62A patent/FI42212B/fi active
-
1964
- 1964-02-07 US US343233A patent/US3373172A/en not_active Expired - Lifetime
- 1964-12-31 OA OA51294A patent/OA02640A/xx unknown
-
1965
- 1965-11-29 SE SE15413/65A patent/SE341398B/xx unknown
- 1965-11-29 SE SE15415/65A patent/SE341399B/xx unknown
- 1965-11-29 SE SE15410/65A patent/SE341397B/xx unknown
- 1965-11-29 SE SE15412/65A patent/SE341401B/xx unknown
- 1965-11-29 SE SE15411/65A patent/SE341400B/xx unknown
- 1965-11-29 SE SE15414/65A patent/SE341394B/xx unknown
- 1965-11-29 SE SE15416/65A patent/SE341848B/xx unknown
- 1965-11-29 SE SE15417/65A patent/SE342445B/xx unknown
-
1966
- 1966-06-28 US US561292A patent/US3362968A/en not_active Expired - Lifetime
- 1966-07-15 US US565671A patent/US3445489A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE341394B (en, 2012) | ||
| JPS54130587A (en) | Carbostyryl derivative | |
| US2374369A (en) | Saturated and unsaturated 17-hydroxyandrostanes, their derivatives and substitution products and process of making same | |
| GB1048231A (en) | New steroid compounds, compositions incorporating them and processes for their preparation | |
| GB1087316A (en) | 7ª-methyl-oestratrienes | |
| GB918729A (en) | Farnesyl-farnesyl hydroquinone | |
| ES299652A1 (es) | Un procedimiento para la preparación de compuestos esteroides | |
| GB1087920A (en) | Novel 10ª-methyl-9ª-steroids | |
| US3309398A (en) | 4-halo and 4-oxygenated-b-nortestosterones and b-norprogesterones | |
| GB929275A (en) | Steroids and their production | |
| US2769822A (en) | Preparing delta-3-keto-etienic acids | |
| GB855022A (en) | Improvements in and relating to carbostyril derivatives | |
| ES269893A1 (es) | Procedimiento de preparaciën de nuevos derivados flavënicos | |
| GB985471A (en) | Androstanes | |
| GB959793A (en) | Improvements in or relating to steroids | |
| GB1081628A (en) | New derivatives of glycyrrhetinic acid | |
| GB1003309A (en) | Novel derivatives of the pregnane series and their production | |
| GB847890A (en) | New compounds of the oestrane series and process for the preparation thereof | |
| GB948631A (en) | Cyclopentanophenanthrene derivatives and process for their production | |
| GB589772A (en) | Processes for producing derivatives of diphenylhexane | |
| Andrews et al. | Hydroxy-steroids. Part XII. Reactions of 5α-ergost-7-en-3-one | |
| GB931785A (en) | New steroid compounds, and processes for their preparation | |
| GB795102A (en) | Improvements in or relating to steroid compounds and the preparation thereof | |
| GB895422A (en) | New photographic developers | |
| GB842343A (en) | Process for the preparation of halogenated 3-keto-steroids |